Skin and soft tissue infection caused by Achromobacter xylosoxidans: report of 14 cases

References

• Schreckenberger PC, Daneshvar MI, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In: Murray PR, Baron JE, Jorgensen JH, Landry ML, Pfaller MA, editors. Manual of clinical microbiology. Washington DC: ASM Press; 2007 pp 770–802.
   Google Scholar
• Yabuuchi E, Oyama A. Achromobacter xylosoxidans n. sp. from human ear discharge. Jpn J Microbiol 1971;15:477–81.
   PubMedGoogle Scholar
• Ridderberg W, Wang M, Norskov-Lauritsen N. Multilocus sequence analysis of isolates from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans. J Clin Microbiol 2012;50:2688–94.
   PubMed Web of Science ®Google Scholar
• Igra-Siegman Y, Chmel H, Cobbs C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol 1980;11:141–5.
   PubMed Web of Science ®Google Scholar
• Duggan JM, Goldstein SJ, Chenoweth CE, Kauffman CA, Bradley SF. Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis 1996;23:569–76.
   PubMed Web of Science ®Google Scholar
• Tena D, Carranza R, Barberá JR, Valdezate S, Garrancho JM, Arranz M, et al. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur J Clin Microbiol Infect Dis 2005;24:727–32.
   PubMed Web of Science ®Google Scholar
• Reina J, Antich M, Siquier B, Alomar P. Nosocomial outbreak of Achromobacter xylosoxidans associated with a diagnostic contrast solution. J Clin Pathol 1988;41:920–3.
   PubMed Web of Science ®Google Scholar
• Gahrn-Hansen B, Alstrup P, Dessau R, Fursted K, Knudsen A, Olsen H, et al. Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers. J Hosp Infect 1988;12:1–6.
   PubMed Web of Science ®Google Scholar
• Aisenberg G, Rolston KV, Safdar A. Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989–2003). Cancer 2004;101:2134–40.
   PubMed Web of Science ®Google Scholar
• Shie SS, Huang CT, Leu HS. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan. J Microbiol Immunol Infect 2005;38:277–82.
   PubMedGoogle Scholar
• Otto-Karg I, Jandl S, Müller T, Stirzel B, Frosch M, Hebestreit H, et al. Validation of Vitek 2 nonfermenting Gram-negative cards and Vitek 2 version 4.02 software for identification and antimicrobial susceptibility testing of nonfermenting Gram-negative rods from patients with cystic fibrosis. J Clin Microbiol 2009;47:3283–8.
   PubMedGoogle Scholar
• Eron LJ, Lipsky BA, Low DE, Nathwabi D, Tice AD, Volturo GA. Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother 2003;52:3–17.
   PubMedGoogle Scholar
• Garner JS, Jarvis R, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128–40.
   PubMed Web of Science ®Google Scholar
• Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20:250–78.
   PubMed Web of Science ®Google Scholar
• Holmes B, Snell JJS, Lapage SP. Strains of Achromobacter xylosoxidans from clinical material. J Clin Pathol 1977; 30:595–601.
   PubMedGoogle Scholar
• Pien FD, Higa HY. Achromobacter xylosoxidans isolates in Hawaii. J Clin Microbiol 1978;7:239–41.
   PubMed Web of Science ®Google Scholar
• Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature. J Clin Microbiol 1988;26:598–9.
   PubMed Web of Science ®Google Scholar
• San Miguel VV, Lavery JP, York JC, Lisse JR. Achromobacter xylosoxidans septic arthritis in a patient with systemic lupus erythematous. Arthritis Rheum 1991;34:1484–5.
   PubMedGoogle Scholar
• Legrand C, Anaissie E. Bacteremia due to Achromobacter xylosoxidans in patients with cancer. Clin Infect Dis 1992; 14:479–84.
   PubMed Web of Science ®Google Scholar
• Tsay RW, Lin LC, Chiou CS, Liao JC, Chen CH, Liu CE, et al. Alcaligenes xylosoxidans bacteremia: clinical features and microbiological characteristics of isolates. J Microbiol Immunol Infect 2005;38:194–9.
   PubMedGoogle Scholar
• Eshwara VK, Mukhopadhyay C, Mohan S, Prakash R, Pai G. Two unique presentations of Achromobacter xylosoxidans infections in clinical settings. J Infect Dev Ctries 2011;5:138–41.
   PubMedGoogle Scholar
• Schoch PE, Cunha BA. Nosocomial Achromobacter xylosoxidans infections. Infect Control Hosp Epidemiol 1988; 9:84–7.
   PubMed Web of Science ®Google Scholar
• Vu-Thien H, Darbord JC, Moissenet D, Dulot C, Dufourcq JB, Marsol P, et al. Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burn unit. Eur J Clin Microbiol Infect Dis 1998;17:724–6.
   PubMed Web of Science ®Google Scholar
• Lipsky BA. Medical treatment of diabetic foot infections. Clin Infect Dis 2004;39:S104–14.
   PubMed Web of Science ®Google Scholar
• Burns JL, Saiman L, Whittier S, Krzewinski, Liu Z, Larone D, et al. Comparison of two commercial systems (Vitek and MicroScan-WalkAway) for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from cystic fibrosis patients. Diagn Microbiol Infect Dis 2001;39:257–60.
   PubMed Web of Science ®Google Scholar
• Saiman L, Chen Y, Gabriel PS, Knirsch C. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob Agents Chemother 2002; 46:1105–7.
   PubMed Web of Science ®Google Scholar